-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The biopharmaceutical industry is an emerging strategic industry in China.
With the intensification of aging, the continuous upgrading of consumption, and the advancement of a series of favorable policies, the scale of the domestic biopharmaceutical industry market continues to expand
.
According to data, the scale of China’s biomedical industry has reached 3.
57 trillion yuan in 2020, and according to the current development trend, it is expected to exceed 4 trillion yuan by 2022 and 5 trillion yuan in 2025, maintaining an average annual growth rate.
Around 8%
.
Pharmaceutical equipment (picture source: pharma.
com) Many places have successively issued policies to promote the high-quality development of the biomedical industry.
In the current situation of the development of the biomedical industry, a series of favorable policies are still being introduced and continuously promoted The biomedical industry is developing towards high quality
.
For example, Jiangsu Province recently issued "Several Policies and Measures on Promoting the High-Quality Development of the Province’s Biomedicine Industry", which clearly stated that by 2024, the basic capabilities of Jiangsu’s biomedical industry and the modernization level of the industrial chain must continue to be improved.
A batch of key core technologies that restrict the high-quality development of the biomedical industry will form a batch of biomedical industry clusters and specialized parks with core competitiveness to create a global influential biomedical industry cluster
.
In addition, Yantai City has recently issued "Several Policies for Promoting the High-Quality Development of the Biomedicine Industry in Yantai", which strongly supports encouraging the innovative development of the biomedical industry and promotes the implementation of major projects
.
The policy pointed out that real money will be provided in 33 sub-fields in nine major areas, and funds as high as 50 million yuan will be given as rewards and support
.
In addition, for the industrialization project of the introduction of original new drugs for the treatment of major diseases, support of up to 100 million yuan will be given in the way of "one matter, one discussion"
.
The above provinces are actually just a microcosm of many places to promote the development of the biomedical industry
.
The industry predicts that in the future, with the advancement of a series of favorable policies, the scale of the entire biomedical industry market will continue to expand, and its development will accelerate towards high quality
.
With the vigorous development of biomedicine, the performance of pharmaceutical machinery companies continues to improve.
With the vigorous development of the biomedical industry, analysis believes that my country's biopharmaceutical equipment industry will also usher in huge market opportunities
.
In fact, this can be seen from the previous third quarter reports of many pharmaceutical equipment companies.
For example, the first three quarter performance forecasts released by Xinlai Yingcai show that the company's net profit is 115 to 130 million yuan, a year-on-year increase of 83.
52%-107.
45%
.
Regarding the performance growth, the company clearly mentioned that it is due to the rapid growth of the company's biomedicine business due to the rapid expansion of domestic vaccine and pharmaceutical manufacturers
.
In addition, Tofflon also mentioned in its recent three-quarter report that the net profit in the first three quarters of 2021 will reach 519 million yuan to 562 million yuan, an increase of 80%-95% year-on-year
.
Regarding the reasons for the growth, it also said that it was due to the gradual performance of new products and new markets in various business segments over the years, including the steady growth of products in multiple fields such as biomacromolecules and cell equipment in the biomedical sector
.
The analysis believes that pharmaceutical equipment has always played an important role in boosting the development of the biomedical industry
.
At present, under the background that policies are vigorously promoting the innovation and development of the biopharmaceutical industry, the biopharmaceutical process involves many links such as separation, liquid preparation, inactivation, and liquid storage.
At the same time, there is an increasing demand for biopharmaceutical equipment products.
The technical requirements for equipment are also becoming higher and higher
.
In this context, the biopharmaceutical equipment industry is expected to face many challenges while welcoming more opportunities
.
In order to better meet the development needs of the biopharmaceutical industry, industry insiders proposed that domestic biopharmaceutical equipment companies should increase their innovation and R&D efforts, starting with improving the technological level to create higher-value biopharmaceutical equipment for users; Further enhance the production, service and supply capabilities of biomedicine
.
According to the author's understanding, in fact, at a time when intelligent and digital technologies continue to promote the development of various industries, pharmaceutical equipment companies have begun to use these technologies to develop a full-process digital solution
.
It is reported that this solution can not only ensure the traceability of all aspects of cell therapy in the future, but also help users optimize the operation of each unit and the entire cell therapy process through the application of these digital solutions.
.
Conclusion In general, the birth of high-quality, high-end biopharmaceutical equipment and technology is of great significance to the development and quality improvement of biopharmaceuticals in China, and will play an increasingly important role
.
In the future, as relevant pharmaceutical equipment companies continue to increase their investment in innovation, develop more high-quality, high-tech equipment, and provide biopharmaceutical companies with more choices of mid-to-high-end equipment.
It is expected to continue to boost the biopharmaceutical industry.
Take a healthier, high-quality development path
.
With the intensification of aging, the continuous upgrading of consumption, and the advancement of a series of favorable policies, the scale of the domestic biopharmaceutical industry market continues to expand
.
According to data, the scale of China’s biomedical industry has reached 3.
57 trillion yuan in 2020, and according to the current development trend, it is expected to exceed 4 trillion yuan by 2022 and 5 trillion yuan in 2025, maintaining an average annual growth rate.
Around 8%
.
Pharmaceutical equipment (picture source: pharma.
com) Many places have successively issued policies to promote the high-quality development of the biomedical industry.
In the current situation of the development of the biomedical industry, a series of favorable policies are still being introduced and continuously promoted The biomedical industry is developing towards high quality
.
For example, Jiangsu Province recently issued "Several Policies and Measures on Promoting the High-Quality Development of the Province’s Biomedicine Industry", which clearly stated that by 2024, the basic capabilities of Jiangsu’s biomedical industry and the modernization level of the industrial chain must continue to be improved.
A batch of key core technologies that restrict the high-quality development of the biomedical industry will form a batch of biomedical industry clusters and specialized parks with core competitiveness to create a global influential biomedical industry cluster
.
In addition, Yantai City has recently issued "Several Policies for Promoting the High-Quality Development of the Biomedicine Industry in Yantai", which strongly supports encouraging the innovative development of the biomedical industry and promotes the implementation of major projects
.
The policy pointed out that real money will be provided in 33 sub-fields in nine major areas, and funds as high as 50 million yuan will be given as rewards and support
.
In addition, for the industrialization project of the introduction of original new drugs for the treatment of major diseases, support of up to 100 million yuan will be given in the way of "one matter, one discussion"
.
The above provinces are actually just a microcosm of many places to promote the development of the biomedical industry
.
The industry predicts that in the future, with the advancement of a series of favorable policies, the scale of the entire biomedical industry market will continue to expand, and its development will accelerate towards high quality
.
With the vigorous development of biomedicine, the performance of pharmaceutical machinery companies continues to improve.
With the vigorous development of the biomedical industry, analysis believes that my country's biopharmaceutical equipment industry will also usher in huge market opportunities
.
In fact, this can be seen from the previous third quarter reports of many pharmaceutical equipment companies.
For example, the first three quarter performance forecasts released by Xinlai Yingcai show that the company's net profit is 115 to 130 million yuan, a year-on-year increase of 83.
52%-107.
45%
.
Regarding the performance growth, the company clearly mentioned that it is due to the rapid growth of the company's biomedicine business due to the rapid expansion of domestic vaccine and pharmaceutical manufacturers
.
In addition, Tofflon also mentioned in its recent three-quarter report that the net profit in the first three quarters of 2021 will reach 519 million yuan to 562 million yuan, an increase of 80%-95% year-on-year
.
Regarding the reasons for the growth, it also said that it was due to the gradual performance of new products and new markets in various business segments over the years, including the steady growth of products in multiple fields such as biomacromolecules and cell equipment in the biomedical sector
.
The analysis believes that pharmaceutical equipment has always played an important role in boosting the development of the biomedical industry
.
At present, under the background that policies are vigorously promoting the innovation and development of the biopharmaceutical industry, the biopharmaceutical process involves many links such as separation, liquid preparation, inactivation, and liquid storage.
At the same time, there is an increasing demand for biopharmaceutical equipment products.
The technical requirements for equipment are also becoming higher and higher
.
In this context, the biopharmaceutical equipment industry is expected to face many challenges while welcoming more opportunities
.
In order to better meet the development needs of the biopharmaceutical industry, industry insiders proposed that domestic biopharmaceutical equipment companies should increase their innovation and R&D efforts, starting with improving the technological level to create higher-value biopharmaceutical equipment for users; Further enhance the production, service and supply capabilities of biomedicine
.
According to the author's understanding, in fact, at a time when intelligent and digital technologies continue to promote the development of various industries, pharmaceutical equipment companies have begun to use these technologies to develop a full-process digital solution
.
It is reported that this solution can not only ensure the traceability of all aspects of cell therapy in the future, but also help users optimize the operation of each unit and the entire cell therapy process through the application of these digital solutions.
.
Conclusion In general, the birth of high-quality, high-end biopharmaceutical equipment and technology is of great significance to the development and quality improvement of biopharmaceuticals in China, and will play an increasingly important role
.
In the future, as relevant pharmaceutical equipment companies continue to increase their investment in innovation, develop more high-quality, high-tech equipment, and provide biopharmaceutical companies with more choices of mid-to-high-end equipment.
It is expected to continue to boost the biopharmaceutical industry.
Take a healthier, high-quality development path
.
